Newsroom | 1703 results
Sorted by: Latest
-
AHF Secures Emergency Hearing to Challenge Florida's Planned Cuts to HIV Drug Program
TALLAHASSEE, Fla.--(BUSINESS WIRE)--An Administrative Law Judge today ordered an emergency hearing for Wednesday, February 25, in AIDS Healthcare Foundation's legal challenge to the Florida Department of Health's plan to slash eligibility for the state's AIDS Drug Assistance Program, known as ADAP. Beginning March 1, the Department plans to cut the qualifying income for the program from roughly $62,600 to $21,000 for an individual, dropping thousands of Floridians living with HIV from the cover...
-
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
FOSTER CITY, Calif. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has entered into a definitive agreement to acquire Arcellx (Nasdaq: ACLX) for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Arcellx is a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incura...
-
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced final data from the LATITUDE phase III trial, confirming its long-acting injectable treatment for HIV, Cabenuva (cabotegravir + rilpivirine), demonstrated superior efficacy in maintaining viral load suppression compared to daily oral therapy in individuals with a history of antiretroviral treatment (ART) adherence challenges.1 The 48-week...
-
California AB 1997 (Lee, D-Milpitas) Speeds Permitting, Spurs Housing at Local Level
SACRAMENTO, Calif.--(BUSINESS WIRE)--California AB 1997 (Lee, D-Milpitas) Speeds Permitting, Spurs Housing at Local Level...
-
Advocates Rally at Florida Capitol to Protect Lifesaving HIV Drug Access for Thousands, says AHF
TALLAHASSEE, Fla.--(BUSINESS WIRE)--Advocates Rally at Florida Capitol to Protect Lifesaving HIV Drug Access for Thousands...
-
AIDS Healthcare Foundation Mourns the Passing of Rev. Jesse Jackson
LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation mourns the passing of longtime civil rights leader Rev. Jesse Jackson, who died today at his home in Chicago after a long illness. Rev. Jackson was one of the first Black clergy to get tested publicly for HIV, helping to remove the stigma of the disease in the African American community. He was also among the earliest to urge his fellow clergy to join the response to HIV in the U.S. and abroad. While perhaps best known for his close relat...
-
Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) being held from February 22-25 in Denver, Colorado. Focusing on expanding therapeutic options to meet the diverse needs of communities affected by HIV, notable late-breaking abstra...
-
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention portfolio and integrase inhibitor (INSTI)-led pipeline at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado from 22-25 February. Jean van Wyk, MBChB, MFPM, Chief Medical Officer at ViiV Healthcare, said: “We are making major advanc...
-
« Just Use It! » AHF célèbre la Journée internationale du préservatif
LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) célèbre la Journée internationale du préservatif (ICD) le 13 février avec un message simple : « Just Use It! », afin de remettre les préservatifs, l’un des outils les plus efficaces et les plus rentables dans la prévention du VIH et des IST, sous les feux de la rampe. Les commémorations organisées dans près de 50 pays par les équipes nationales d’AHF allieront divertissement, créativité et éducation à la distribution gratuite de pré...
-
Florida Covers Up AIDS Cuts by Asking for $700K Ransom Says AHF
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Florida Covers Up AIDS Cuts by Asking for $700K Ransom...